Interplay between mesenchymal stromal cells and immune system: clinical applications in immune-related diseases

Mesenchymal stromal cells (MSCs) are a mesodermal stem cell population, with known self-renewal and multilineage differentiation properties. In the last century, MSCs have been widely used in regenerative medicine and tissue engineering approaches. MSCs initially were isolated from bone marrow aspir...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Panagiotis Mallis, Efstathios Michalopoulos, Theofanis Chatzistamatiou, Catherine Stavropoulos Giokas
Formato: article
Lenguaje:EN
Publicado: Open Exploration Publishing Inc. 2021
Materias:
Acceso en línea:https://doaj.org/article/d941e78d1e4b4652af18478cca33e576
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d941e78d1e4b4652af18478cca33e576
record_format dspace
spelling oai:doaj.org-article:d941e78d1e4b4652af18478cca33e5762021-11-24T06:00:16ZInterplay between mesenchymal stromal cells and immune system: clinical applications in immune-related diseases10.37349/ei.2021.000102768-6655https://doaj.org/article/d941e78d1e4b4652af18478cca33e5762021-06-01T00:00:00Zhttps://www.explorationpub.com/Journals/ei/Article/100310https://doaj.org/toc/2768-6655Mesenchymal stromal cells (MSCs) are a mesodermal stem cell population, with known self-renewal and multilineage differentiation properties. In the last century, MSCs have been widely used in regenerative medicine and tissue engineering approaches. MSCs initially were isolated from bone marrow aspirates, but currently have been identified in a great number of tissues of the human body. Besides their utilization in regenerative medicine, MSCs possess significant immunoregulatory/immunosuppressive properties, through interaction with the cells of innate and adaptive immunity. MSCs can exert their immunomodulatory properties with either cell-cell contact or via paracrine secretion of molecules, such as cytokines, growth factors and chemokines. Of particular importance, the MSCs’ immunomodulatory properties are explored as promising therapeutic strategies in immune-related disorders, such as autoimmune diseases, graft versus host disease, cancer. MSCs may also have an additional impact on coronavirus disease-19 (COVID-19), by attenuating the severe symptoms of this disorder. Nowadays, a great number of clinical trials, of MSC-mediated therapies are evaluated for their therapeutic potential. In this review, the current knowledge on cellular and molecular mechanisms involved in MSC-mediated immunomodulation were highlighted. Also, the most important aspects, regarding their potential application in immune-related diseases, will be highlighted. The broad application of MSCs has emerged their role as key immunomodulatory players, therefore their utilization in many disease situations is full of possibilities for future clinical treatment.Panagiotis MallisEfstathios MichalopoulosTheofanis ChatzistamatiouCatherine Stavropoulos GiokasOpen Exploration Publishing Inc.articlemesenchymal stromal cellsimmunomodulationadaptive immunitygraft versus host diseaseautoimmune disorderscovid-19Immunologic diseases. AllergyRC581-607ENExploration of Immunology, Vol 1, Iss 2, Pp 112-139 (2021)
institution DOAJ
collection DOAJ
language EN
topic mesenchymal stromal cells
immunomodulation
adaptive immunity
graft versus host disease
autoimmune disorders
covid-19
Immunologic diseases. Allergy
RC581-607
spellingShingle mesenchymal stromal cells
immunomodulation
adaptive immunity
graft versus host disease
autoimmune disorders
covid-19
Immunologic diseases. Allergy
RC581-607
Panagiotis Mallis
Efstathios Michalopoulos
Theofanis Chatzistamatiou
Catherine Stavropoulos Giokas
Interplay between mesenchymal stromal cells and immune system: clinical applications in immune-related diseases
description Mesenchymal stromal cells (MSCs) are a mesodermal stem cell population, with known self-renewal and multilineage differentiation properties. In the last century, MSCs have been widely used in regenerative medicine and tissue engineering approaches. MSCs initially were isolated from bone marrow aspirates, but currently have been identified in a great number of tissues of the human body. Besides their utilization in regenerative medicine, MSCs possess significant immunoregulatory/immunosuppressive properties, through interaction with the cells of innate and adaptive immunity. MSCs can exert their immunomodulatory properties with either cell-cell contact or via paracrine secretion of molecules, such as cytokines, growth factors and chemokines. Of particular importance, the MSCs’ immunomodulatory properties are explored as promising therapeutic strategies in immune-related disorders, such as autoimmune diseases, graft versus host disease, cancer. MSCs may also have an additional impact on coronavirus disease-19 (COVID-19), by attenuating the severe symptoms of this disorder. Nowadays, a great number of clinical trials, of MSC-mediated therapies are evaluated for their therapeutic potential. In this review, the current knowledge on cellular and molecular mechanisms involved in MSC-mediated immunomodulation were highlighted. Also, the most important aspects, regarding their potential application in immune-related diseases, will be highlighted. The broad application of MSCs has emerged their role as key immunomodulatory players, therefore their utilization in many disease situations is full of possibilities for future clinical treatment.
format article
author Panagiotis Mallis
Efstathios Michalopoulos
Theofanis Chatzistamatiou
Catherine Stavropoulos Giokas
author_facet Panagiotis Mallis
Efstathios Michalopoulos
Theofanis Chatzistamatiou
Catherine Stavropoulos Giokas
author_sort Panagiotis Mallis
title Interplay between mesenchymal stromal cells and immune system: clinical applications in immune-related diseases
title_short Interplay between mesenchymal stromal cells and immune system: clinical applications in immune-related diseases
title_full Interplay between mesenchymal stromal cells and immune system: clinical applications in immune-related diseases
title_fullStr Interplay between mesenchymal stromal cells and immune system: clinical applications in immune-related diseases
title_full_unstemmed Interplay between mesenchymal stromal cells and immune system: clinical applications in immune-related diseases
title_sort interplay between mesenchymal stromal cells and immune system: clinical applications in immune-related diseases
publisher Open Exploration Publishing Inc.
publishDate 2021
url https://doaj.org/article/d941e78d1e4b4652af18478cca33e576
work_keys_str_mv AT panagiotismallis interplaybetweenmesenchymalstromalcellsandimmunesystemclinicalapplicationsinimmunerelateddiseases
AT efstathiosmichalopoulos interplaybetweenmesenchymalstromalcellsandimmunesystemclinicalapplicationsinimmunerelateddiseases
AT theofanischatzistamatiou interplaybetweenmesenchymalstromalcellsandimmunesystemclinicalapplicationsinimmunerelateddiseases
AT catherinestavropoulosgiokas interplaybetweenmesenchymalstromalcellsandimmunesystemclinicalapplicationsinimmunerelateddiseases
_version_ 1718415947145936896